SG Americas Securities
TNDM icon

SG Americas Securities’s Tandem Diabetes Care TNDM Stock Holding History

SG Americas Securities’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-22,500
Closed -$46K – 3475
2020
Q3 		$46K Buy
22,500
+200
+0.9% +$21K ﹤0.01% 2529
2020
Q2 		$167K Buy
+22,300
New +$1.78M ﹤0.01% 3000

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

SG Americas Securities's TNDM Position: Q2 2026 in Review

SG Americas Securities reduced its Tandem Diabetes Care (TNDM) stake by 73% in Q2 2026, selling an estimated $423K and leaving 8,795 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #2979.

SG Americas Securities first reported a position in TNDM in Q3 2018 and has held it in 31 quarters since. The position peaked at $5.7M in Q2 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • SG Americas Securities held 8,795 shares of Tandem Diabetes Care worth $133K as of Q2 2026.
  • SG Americas Securities sold 24,227 Tandem Diabetes Care shares in Q2 2026, an estimated $423K.
  • Tandem Diabetes Care made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2979 holding.
  • SG Americas Securities first reported a position in Tandem Diabetes Care in Q3 2018 and has held it in 31 quarters since.
  • SG Americas Securities's Tandem Diabetes Care position peaked at $5.7M in Q2 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.